A comparative sfudy of venlafaxine and imipramine for deprossive patients
FU Nan-yan
Abstract
FU Nan-yan
Abstract
Objective The aim of this study was to etermine the officacy and safety of ven afaxine to the patients with depression.Methods Patients who met CCMD-3 criteria for depressive episode were randonizde into two groups:venlafaxine group(n=40) and imipramine group(n=30).The range of dosane for the two experiment drugs was 150~300mg/d,the treatment duration was 4 weeks.The HAMD,HAMA,CGI,TESS and related lab tests were employed for assessing the treatment effeciteness and side effects.Results At the end of treatments,the scores of HAMA in both treatment groups decreased significantly compared with baseline(P0.01).Total clinical effective rates were 82.5% in venlafaxine group and 77% in imipramine group,which was no significant difference between two groups.However,patients in venlafaxine group,reported much tewer side effects than those in imipramine group,especially in the items of dry month,constipation,and urinary distress on TESS((P0.01=).Conclusion Venlafaxine is an effectiye antidepressants,with less side effects and better safety safety compared with imipramine.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective The aim of this study was to etermine the officacy and safety of ven afaxine to the patients with depression.Methods Patients who met CCMD-3 criteria for depressive episode were randonizde into two groups:venlafaxine group(n=40) and imipramine group(n=30).The range of dosane for the two experiment drugs was 150~300mg/d,the treatment duration was 4 weeks.The HAMD,HAMA,CGI,TESS and related lab tests were employed for assessing the treatment effeciteness and side effects.Results At the end of treatments,the scores of HAMA in both treatment groups decreased significantly compared with baseline(P0.01).Total clinical effective rates were 82.5% in venlafaxine group and 77% in imipramine group,which was no significant difference between two groups.However,patients in venlafaxine group,reported much tewer side effects than those in imipramine group,especially in the items of dry month,constipation,and urinary distress on TESS((P0.01=).Conclusion Venlafaxine is an effectiye antidepressants,with less side effects and better safety safety compared with imipramine.
Key concepts: Venlafaxine, Imipramine, Hamd, Constipation, Depression (economics), Medicine, Internal medicine, Major depressive episode